Matinas BioPharma Holdings, Inc. (MTNB)
| Market Cap | 1.12M+40.6% |
| Revenue (ttm) | n/a |
| Net Income | n/a+62.7% |
| EPS | n/a+69.3% |
| Shares Out | 427.08K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 81,223 |
| Open | 2.73 |
| Previous Close | 2.77 |
| Day's Range | 2.61 - 2.85 |
| 52-Week Range | 2.26 - 28.95 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | n/a |
| Earnings Date | n/a |
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About MTNB
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.
$MTNB stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in MTNB holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by MTNB's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
MTNB Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New MTNB patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to MTNB from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in MTNB
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $7.93K |
Estimated from each fund’s disclosed top holdings × AUM
MTNB Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from MTNB’s recent data — informational, not investment advice